In vivo, the combined application of CAST-crRNA/FCS NPs and BSA@FBZ/FCS NPs markedly downregulated PDL1 expression with negligible off-target effect and reshaped the immune microenvironment in tumor tissues, significantly inhibiting BCa tumor growth and prolonging mouse survival (scheme 1). This evidence concerns the gene CD274 and neoplasm.